Eukaryotic organisms as well as some prokaryotes and viruses contain sphing
olipids, which are defined by a common structural feature, i.e., a "sphingo
id base" backbone such as D-erythro-l,3-dihydroxy, 2-aminooctadec-4-ene (sp
hingosine). The sphingolipids of mammalian tissues, lipoproteins, and milk
include ceramides, sphingomyelins, cerebrosides, gangliosides and sulfatide
s; plants, fungi and yeast have mainly cerebrosides and phosphoinositides.
The total amounts of sphingolipids in food vary considerably, from a few mi
cromoles per kilogram (fruits) to several millimoles per kilogram in rich s
ources such as dairy products, eggs and soybeans. With the use of the limit
ed data available, per capita sphingolipid consumption in the United States
can be estimated to be on the order of 150-180 mmol (similar to 115-140 g)
per year, or 0.3-0.4 g/d. There is no known nutritional requirement for sp
hingolipids; nonetheless, they are hydrolyzed throughout the gastrointestin
al tract to the same categories of metabolites (ceramides and sphingoid bas
es) that are used by cells to regulate growth, differentiation, apoptosis a
nd other cellular functions. Studies with experimental animals have shown t
hat feeding sphingolipids inhibits colon carcinogenesis, reduces serum LDL
cholesterol and elevates HDL, suggesting that sphingolipids represent a "fu
nctional" constituent of food. Sphingolipid metabolism can also be modified
by constituents of the diet, such as cholesterol, fatty acids and mycotoxi
ns (fumonisins), with consequences for cell regulation and disease. Additio
nal associations among diet, sphingolipids and health are certain to emerge
as more is learned about these compounds.